Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2112950
Abstract: ABSTRACT Introduction Lisdexamfetamine dimesylate (LDX) is a prodrug approved for attention deficit/hyperactivity disorder and for moderate-to-severe binge eating disorder in adults in some countries. Area covered We aimed to specify the abuse potential of LDX…
read more here.
Keywords:
expert opinion;
potential abuse;
lisdexamfetamine;
review ... See more keywords